Pierre-André Lafon

5PUBLICATIONS
29CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular medicineGene and molecular therapyGene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Apr 14, 2026
Divergent Roles of mGlu2 and mGlu3 Receptors in Amyloid-β Production and Cognitive Dysfunctions in Alzheimer's Disease.

Pierre-André Lafon, Mireille Elodie Tsitokana, Ugo Guy Alenda

|Jul 23, 2025
Nanobody therapy rescues behavioural deficits of NMDA receptor hypofunction.

Mathieu Oosterlaken, Angelina Rogliardo, Tatiana Lipina

|Jan 26, 2024
TrkB receptor interacts with mGlu2 receptor and mediates antipsychotic-like effects of mGlu2 receptor activation in the mouse.

Clémentine Eva Philibert, Candice Disdier, Pierre-André Lafon

|Feb 11, 2023
Targeting the Brain with Single-Domain Antibodies: Greater Potential Than Stated So Far?

Mireille Elodie Tsitokana, Pierre-André Lafon, Laurent Prézeau

|Jun 10, 2022
Nanobody-based sensors reveal a high proportion of mGlu heterodimers in the brain.

Jiyong Meng, Chanjuan Xu, Pierre-André Lafon

Pageof 1

Frequent Collaborators

5 joint publications

Philippe Rondard

4 joint publications

Jean-Philippe Pin

3 joint publications

Patrick Chames

3 joint publications

Jianfeng Liu